Skip to main content

View full-text article in PMC

. 2020 Feb 14;5:9. doi: 10.1038/s41392-020-0106-1

Table 2.

Diagnosis and treatment in patient with AKI.

	Biomarkers/novel therapy	Patients
Diagnosis	[TIMP-2]•[IGFBP7] ≤0.3 Low risk of AKI; >0.3 >92% of stage2/3 AKI; (FDA approved)¹⁴⁵	Postoperative cardiovascular surgery
		Shock/hemodynamically unstable
		Sepsis
		Postoperative major non-cardiovascular surgery
		Cardiac arrest
		Oliguria after acute resuscitation
	FGF-23 (Clinical trial)	Severe sepsis/septic shock
	IGF-1⁸⁹	In the intensive care unit
	VEGF VEGFR-1¹⁴⁸	Cardiac surgery
Treatment	HGF mimetic (ANG-3777, clinical trial)	Kidney transplantation Cardiac surgery